Effect of minocycline on carotid atherosclerotic plaques

References

• , Writing Group MembersLloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al.. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:46–215.
   PubMed Web of Science ®Google Scholar
• Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes. Part I: introduction and cytokines. Circulation. 2006;113:72–5.
   PubMed Web of Science ®Google Scholar
• Bäck M, Ketelhuth DF, Agewall S. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis. 2010;52:410–28.
   PubMed Web of Science ®Google Scholar
• Pasterkamp G, Schoneveld AH, Hijnen DJ, de Kleijn DP, Teepen H, van der Wal AC, et al.. Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis. 2000;150:245–53.
   PubMed Web of Science ®Google Scholar
• Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie. 2005;87:361–8.
   PubMed Web of Science ®Google Scholar
• Schmidt R, Bültmann A, Fischel S, Gillitzer A, Cullen P, Walch A, et al.. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor {kappa}B dependent inflammation in monocytes. Circ Res. 2008;102:302–9.
   PubMed Web of Science ®Google Scholar
• Yoon YW, Kwon HM, Hwang KC, Choi EY, Hong BK, Kim, et al.. Upstream regulation of matrix metalloproteinase by EMMPRIN: extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque. Atherosclerosis. 2005;181:37–44.
   Web of Science ®Google Scholar
• Tang Y, Nakada MT, Kesavan P, McCabe F, Millar H, Rafferty P, et al.. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and Matrix MetalloProteinases. Cancer Res. 2005;65:3193–9.
   PubMed Web of Science ®Google Scholar
• Seizer P, Schönberger T, Schött M, Lang MR, Langer HF, Bigalke, et al.. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis. 2010;209:51–7.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim WJ, Kim H, Suk K, Lee WH. The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis. Immune Netw. 2009;9:90–7.
   PubMedGoogle Scholar
• Kim HS, Suh YH. Minocycline and neurodegenerative diseases. Behav Brain Res. 2009;196:168–79.
   PubMed Web of Science ®Google Scholar
• Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A, et al.. Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology. 2007;69:1404–10.
   PubMed Web of Science ®Google Scholar
• Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist. 2005;11:308–22.
   PubMed Web of Science ®Google Scholar
• Nagel S, Su Y, Horstmann S, Heiland S, Gardner H, Koziol J, et al.. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat-Effects on BBB breakdown and MMP expression in the acute and subacute phase. Brain Res. 2008;1188:198–6.
   PubMed Web of Science ®Google Scholar
• Chen WQ, Zhong L, Zhang L, Ji XP, Zhang M, Zhao YX, et al.. Oral rapamycin attenuates inflammation and enhances stability of atherosclerotic plaques in rabbits independent of serum lipid levels. Br J Pharmacol. 2009;156:941–51.
   PubMed Web of Science ®Google Scholar
• Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22:788–92.
   PubMed Web of Science ®Google Scholar
• Gotlieb AI. Atherosclerosis and acute coronary syndromes. Cardiovasc Pathol. 2005;14:181–4.
   PubMed Web of Science ®Google Scholar
• Wolfgang K, Natalie K. Biomarkers of Atherosclerotic Plaque Instability and Rupture. Arterioscler Thromb Vasc Biol. 2007;27:15–26.
   PubMed Web of Science ®Google Scholar
• de Nooijer R, Verkleij CJ, von der Thüsen JH, Jukema JW, van der Wall EE, van Berkel TJ, et al.. Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol. 2006; 26:340–6.
   PubMed Web of Science ®Google Scholar
• Yue HH, Leng N, Wu ZB, Li HM, Li XY, Zhu P. Expression of CD147 on phorbol-12-myristate-13-acetate (PMA)-treated U937 cells differentiating into foam cells. Arch Biochem Biophys. 2009;85:30–4.
   Web of Science ®Google Scholar
• Ohshima S, Fujimoto S, Petrov A, Nakagami H, Haider N, Zhou J, et al.. Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging. J Am Coll Cardiol. 2010;55:1240–9.
   PubMed Web of Science ®Google Scholar
• Arboix A, García-Eroles L, Oliveres M, Targa C, Balcells M, Massons J. Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol. 2010;18;10–47.
   Google Scholar
• Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, et al.. Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke. 2011; 42;1314–9.
   PubMed Web of Science ®Google Scholar
• Madan M, Bishayi B, Hoge M, Messas E, Amar S. Doxycycline affects diet- and bacteria-associated atherosclerosis in an ApoE heterozygote murine model: cytokine profiling implications. Atherosclerosis. 2007; 190:62–72.
   PubMed Web of Science ®Google Scholar
• Huang C, Li R, Zeng Q, Ding Y, Zou Y, Mao X, et al.. Effect of minocycline postconditioning and ischemic postconditioning on myocardial ischemia-reperfusion injury in atherosclerosis rabbits. J Huazhong Univ Sci Technolog Med Sci. 2012;32:524–9.
   PubMed Web of Science ®Google Scholar
• Haider N, Hartung D, Fujimoto S, Petrov A, Kolodgie FD, Virmani R, et al.. Dual molecular imaging for targeting metallo- proteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol. 2009;16:753–62.
   PubMed Web of Science ®Google Scholar
• Pinney SP, Chen HJ, Liang D, Wang X, Schwartz A, Rabbani LE. Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury. J Cardiovasc Pharmacol. 2003;42:469–76.
   PubMed Web of Science ®Google Scholar